Clinical trials
Phase 2 Primary Myelofibrosis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| AbbVie | 1 |
| CTI BioPharma | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Geron Corporation | 1 |
| GlaxoSmithKline | 1 |
| Hoffmann-La Roche | 1 |
| Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) | 1 |
| Italfarmaco | 1 |
| John Mascarenhas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 15 |
| Polycythemia Vera | 3 |
| Thrombocythemia, Essential | 3 |
| Anemia | 2 |
| Myeloproliferative Disorders | 2 |
| Thrombocytopenia | 2 |
| Fibrosis | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Megakaryoblastic, Acute | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.